| pubmed-article:19946027 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19946027 | lifeskim:mentions | umls-concept:C0032143 | lld:lifeskim |
| pubmed-article:19946027 | lifeskim:mentions | umls-concept:C0019080 | lld:lifeskim |
| pubmed-article:19946027 | lifeskim:mentions | umls-concept:C0796392 | lld:lifeskim |
| pubmed-article:19946027 | lifeskim:mentions | umls-concept:C0271084 | lld:lifeskim |
| pubmed-article:19946027 | lifeskim:mentions | umls-concept:C2699708 | lld:lifeskim |
| pubmed-article:19946027 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:19946027 | pubmed:dateCreated | 2010-4-13 | lld:pubmed |
| pubmed-article:19946027 | pubmed:abstractText | To evaluate the efficacy and safety of pars plana vitrectomy (ppV) with subretinal coapplication of recombinant tissue plasminogen activator (rtPA) and bevacizumab, and fluid-gas exchange for neovascular age-related macular degeneration (AMD) with submacular haemorrhage (SMH). | lld:pubmed |
| pubmed-article:19946027 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19946027 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19946027 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19946027 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19946027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19946027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19946027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19946027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19946027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19946027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19946027 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19946027 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19946027 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:19946027 | pubmed:issn | 1468-2079 | lld:pubmed |
| pubmed-article:19946027 | pubmed:author | pubmed-author:RoiderJJ | lld:pubmed |
| pubmed-article:19946027 | pubmed:author | pubmed-author:KlattCC | lld:pubmed |
| pubmed-article:19946027 | pubmed:author | pubmed-author:HillenkampJJ | lld:pubmed |
| pubmed-article:19946027 | pubmed:author | pubmed-author:TreumerFF | lld:pubmed |
| pubmed-article:19946027 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19946027 | pubmed:volume | 94 | lld:pubmed |
| pubmed-article:19946027 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19946027 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19946027 | pubmed:pagination | 48-53 | lld:pubmed |
| pubmed-article:19946027 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:meshHeading | pubmed-meshheading:19946027... | lld:pubmed |
| pubmed-article:19946027 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:19946027 | pubmed:articleTitle | Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage. | lld:pubmed |
| pubmed-article:19946027 | pubmed:affiliation | Department of Ophthalmology, University Medical Center Schleswig-Holstein, Arnold-Heller Str 3, Haus 25, D-24105 Kiel, Germany. | lld:pubmed |
| pubmed-article:19946027 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19946027 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19946027 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19946027 | lld:pubmed |
